Pharmacological Control of Lipid Metabolism- 4th International Symposium on Drugs Affecting Lipid Metabolism- Papers and Abstracts

Opening Remarks.- Newer Developments in Lipid Biochemistry.- Synthesis and Secretion of Plasma Lipoproteins.- The Apolipoproteins.- Mechanisms of Hyperlipoproteinemia.- Clearing Factor Lipase and Its Role in the Regulation of Triglyceride Utilization. Studies on the Enzyme in Adipose Tissue.- Hormonal Control of Lipolysis in Adipose Tissue.- The Role of Cyclic 3?5?-AMP and Its Derivatives in Lipid and Carbohydrate Metabolism.- Biochemical Changes in the Artery Wall during Genesis and Regression of Atheromatous Lesions.- Newer Aspects of Drugs Affecting Lipid Metabolism.- Effect of Some Drugs on Free Fatty Acids and Triglycerides in Plasma and Tissues.- Effect of Drugs on Plasma Triglyceride Metabolism.- The Economy of Cholesterol in Man: Drug Effects.- Effect of Drugs on the Metabolism of Bile Acids.- Hypolipidemic Drugs and Lipoprotein Metabolism.- Serum and Tissue Lipid Metabolism and Effect of Nicotinic Acid in Different Types of Hype rlipidemia.- The Combined Use of Clofibrate and Anion Exchange in the Treatment of Hypercholesterolemia.- Can Heart Disease be Postponed or Prevented?.- Atherogenic and Thrombogenic Mosaic.- Risk Factors in Coronary Heart Disease: Possibilities of Prevention in the Federal Republic of West Germany.- Role of Diet in the Primary Prevention of Coronary Heart Disease.- Prospects with Multifactorial Approaches Emphasizing Improvement in Life Style.- Cholesterol-Lowering in Man.- Ischemic Heart Disease: A Secondary Prevention Trial using Clofibrate (Atromid-S).- Closing Session.- Antilipemic Drugs and the Position of the FDA.- Concluding Remarks.- Abstracts of Submitted Papers.- Author Index.